NCT07574931

Brief Summary

Our observational study aim to to evaluate the incidence of Tachyarrhythmia in patients with congenital heart diseases (corrected/non corrected) and the effectiveness of catheter ablation.RF catheter ablation was performed to all patients and follow up for recurrence was done for one year.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 16, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 8, 2026

Completed
Last Updated

May 8, 2026

Status Verified

April 1, 2024

Enrollment Period

11 months

First QC Date

April 21, 2026

Last Update Submit

May 2, 2026

Conditions

Keywords

Congenital heart disease, Catheter ablation, arrhythmia, Radiofrequency, 3D Mapping, tachycardia.Outcome

Outcome Measures

Primary Outcomes (2)

  • the rate of acute success of catheter ablation

    defined as termination of the clinical arrhythmia with non-inducibility of this clinical arrhythmia during Catheter ablation

    From timing of catheter ablation till about one hour

  • rate of recurrence of tachyarrhythmias after catheter ablation

    one year

Secondary Outcomes (1)

  • The types of Tachyarrhythmia in patients with congenital heart diseases

    One year

Study Arms (1)

Patients with congenital heart diseases with arrhythmia

Patients with congenital heart diseases (corrected / non corrected) with documented arrhythmia or without documented arrhythmia but frequent palpitations.

Eligibility Criteria

Age3 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with congenital heart diseases (corrected / non corrected) with arrhythmia

You may qualify if:

  • Patients with congenital heart diseases (corrected / non corrected) with documented arrhythmia
  • Patients with congenital heart diseases without documented arrhythmia but frequent palpitations.

You may not qualify if:

  • Pregnant
  • Patients with unstable hemodynamics
  • End stage diseases e.g.: cancer stage IV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo university hospitals

Cairo, 11956, Egypt

Location

MeSH Terms

Conditions

Heart Defects, CongenitalArrhythmias, CardiacTachycardia

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPathologic ProcessesPathological Conditions, Signs and SymptomsCardiac Conduction System Disease

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer of Critical Care Medicine

Study Record Dates

First Submitted

April 21, 2026

First Posted

May 8, 2026

Study Start

April 16, 2024

Primary Completion

February 26, 2025

Study Completion

February 28, 2026

Last Updated

May 8, 2026

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations